- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02473744
Oedematous Lower Limb Subcutaneous Drainage in Palliative Care (DSOPAL)
- Background : Edema of lower extremities is a concern ranging from 19 % to 60% of palliative cancer patients. Lymphedema decreases mobility, induces pain, impacts daily activities, esthetic and behavior. Usual treatment is based on diuretics and physiotherapy but is often unsuccessful. In case of conventional treatment failure, in palliative care, subcutaneous drainage can be discussed with the patients. The technique is simple, easy to use but remains off the record. Since 2004, 23 cases were reported with various methods. All the cases reported were undertaken with various technical approaches and efficacy criteria.
- Purpose : Investigator hypothesize that the subcutaneous drainage of edema (SDO) is effective in case of refractory lymphedema of the lower limbs in palliative care and leads to an improvement in QOL in terms of behavioral and autonomy.
Study Overview
Detailed Description
• Abstract : In palliative care, lymphedema results from various associations of cancer, hypoalbuminemia, electrolytic disturbances or organ failure. The lymphatic circulation cannot be summarized by the Starling's equation and obstruction cannot explain everything. An interstitial hypothesis underlines the role of the lymphatic pump and edema volume can be a crucial point. The SDO, via the direct liquid removal, can restore the lymphatic pump function. This volumetric effect can explain the long time effect of the SDO and the large range of liquid amount reported in effective SDO. The superficial lymphatic system, in the superficial layer of derma, drains 80 % of lymph flow. In edema, the increased volume leads to the creation of subcutaneous interconnected lacunas. The subcutaneous site for drainage is justified.
After topic anesthesia, three subcutaneous channels are created on the ankle's medial face of the edematous limbs and liquids are absorbed by pads. An additional drainage can be done on the external face of the thigh with liquid collecting bags in bedridden patients.
The study includes clinical examination, total and segmental bioelectrical impedance measured at J0, J4 and on exit or at J7 at the latest and daily weight, umbilic abdominal perimeters and segmental circumferences and QOL evaluation before and after SDO. Bioelectrical impedance is collected from hand-foot, thigh root-foot and under patella calf - foot electrodes. Segmental circumferences are collected at thigh, calf and ankle points identified from bone relief distance.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33000
- University Hospital
-
Limoges, France, 87042
- University Hospital
-
Nantes, France, 40031
- University Hospital
-
Perigueux, France, 24019
- Hospital
-
Toulouse, France, 31059
- University Hospital
-
Toulouse, France, 31027
- Joseph Ducuing hospital
-
Valenciennes, France, 59300
- Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 18
- palliative care patients
- Karnofsky Scale < 50%
- Uni or bilateral lower limb oedema even if associated with lumbar or pelvi-scrotal oedema or ascitis whatever etiology involved (cancer, organ failure, hypoalbuminemia…)
- Effective Social security regimen affiliation
- Signed informed consent
Exclusion Criteria:
- Refusal to take part in the study
- Local anesthesic contraindication
- Infected skin lesions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Oedematous lower limb subcutaneous drainage
In case of lymphoedema in palliative situation, a subcutaneous drainage can be performed.
It is a simple method, easy to use.
After topic analgesia, three subcutaneous channels are created and an absorbent pad collects the lymphatic fluid.
|
After topic analgesia, three subcutaneous channels are created and an absorbent pad collects the lymphatic fluid.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Karnofsky's scale
Time Frame: 7 days
|
Change in autonomy evaluated by Karnofsky's scale between Day 7 and Day 0
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Karnofsky's scale
Time Frame: 4 Days
|
Change in autonomy evaluated by Karnofsky's scale between Day 4 and Day 0
|
4 Days
|
|
The 15th item of the European Organisation for Research and Treatment of Cancer quality of life questionnaires of palliative cancer care patients (EORTC QLQ C15 PAL),
Time Frame: 4 days and 7 days
|
Changes in quality of life evaluated by the 15th item of the EORTC QLQ C15 PAL scale between between Day 4/Day 7 and Day 0
|
4 days and 7 days
|
|
Modify Dermatology Life Quality Index (MDLQI)
Time Frame: 4 days and 7 days
|
Changes in quality of life related to lymphedema evaluated by the MDLQI between Day 4/Day 7 and Day 0
|
4 days and 7 days
|
|
Verbal numeric scale for pain
Time Frame: 4 days and 7 days
|
Changes in pain evaluated by the verbal numeric scale between Day 4/Day 7 and Day 0
|
4 days and 7 days
|
|
Bioelectrical impedance analysis of lower limbs, calves and thighs
Time Frame: 4 days and 7 days
|
Changes in bioelectrical impedance of lower limbs, calves and thighs between Day 4/Day 7 and Day 0.
|
4 days and 7 days
|
|
Segmental limb circumferences measurement
Time Frame: 4 days and 7 days
|
Variation of the physical measures in time.
Changes in segmental limb circumferences between Day 4/Day 7 and Day 0
|
4 days and 7 days
|
|
Abdominal perimeter measurement
Time Frame: 4 days and 7 days
|
Variation of the physical measures in time.
Changes in abdominal perimeter between Day 4/Day 7 and Day 0
|
4 days and 7 days
|
|
Weight measurement
Time Frame: 4 days and 7 days
|
Variation of the physical measures in time.
Changes in weight between Day 4/Day 7 and Day 0
|
4 days and 7 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bertrand SARDIN, MD, University Hospital, Limoges
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- I14010 DSOPAL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edema
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
Curacle Co., Ltd.Not yet recruitingDiabetic Macular Edema | Diabetic Macular Edema (DME) | DME
-
Alexandria UniversityRecruitingDiabetic Macular Edema | Center-involved Diabetic Macular EdemaEgypt
-
Hoffmann-La RocheCompletedDiabetic Macular Edema | Uveitic Macular EdemaUnited States
-
Eye-yon MedicalCompletedChronic Cornel EdemaNetherlands, Israel, Germany, Spain
-
Postgraduate Institute of Medical Education and...CompletedDiabetic Macular Edema | Vision Disorders | Macular Edema, Cystoid | Clinically Significant Macular EdemaIndia
-
University of RochesterNeuroMetrix, Inc.Terminated
-
Luca MarinEnrolling by invitation
Clinical Trials on subcutaneous drainage
-
Centre Hospitalier Universitaire de NiceCompleted
-
Beijing Friendship HospitalRecruitingAll Diseases That Require Gastrointestinal Open SurgeryChina
-
Duke UniversityCareFusionCompletedPleural Effusion, MalignantUnited States
-
Prof A Gruca Teaching HospitalCompletedBleeding | Hip Osteoarthritis
-
Peking University People's HospitalUnknownKnee Osteoarthritis
-
Hepatopancreatobiliary Surgery Institute of Gansu...Completed
-
Kantonsspital AarauCompleted
-
University Hospital, RouenUnknownInfectious Pleural EffusionFrance
-
Wakayama Medical UniversityCompletedPancreatic Cancer | Bile Duct Cancer | Pancreatitis | Duodenal Cancer | Ampullary CancerJapan
-
Maciej Stukan, MD, PhDUnknown